Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants

The Journal of Clinical Endocrinology and Metabolism
D TripathyRalph A DeFronzo

Abstract

Chronic hyperglycemia worsens skeletal muscle insulin resistance and β-cell function. However, the effect of sustained physiologic hyperglycemia on hepatic insulin sensitivity is not clear. To examine the effect of sustained physiologic hyperglycemia (similar to that observed in patients with type 2 diabetes) on endogenous (primarily reflecting hepatic) glucose production (EGP) in healthy individuals. Volunteers participated in a three-step hyperinsulinemic (10, 20, 40 mU/m2 per minute) euglycemic clamp before and after a 48-hour glucose infusion to increase plasma glucose concentration by ∼40 mg/dL above baseline. EGP was measured with 3-3H-glucose before and after chronic glucose infusion. Sixteen persons with normal glucose tolerance [eight with and eight without a family history (FH) of diabetes] participated in the study. EGP. Basal EGP increased following 48 hours of glucose infusion (from a mean ± SEM of 2.04 ± 0.08 to 3.06 ± 0.29 mg/kgffm⋅ min; P < 0.005). The hepatic insulin resistance index (basal EGP × fasting plasma insulin) markedly increased following glucose infusion (20.1 ± 1.8 to 51.7 ± 6.6; P < 0.005) in both FH+ and FH- subjects. Sustained physiologic hyperglycemia for as little as 48 hours increased the rate...Continue Reading

References

Jan 1, 1979·The Journal of Clinical Endocrinology and Metabolism·J E LiljenquistD Rabinowitz
Oct 1, 1992·The Journal of Clinical Investigation·I MagnussonG I Shulman
Jun 1, 1990·Diabetes Care·L RossettiR A DeFronzo
Jan 1, 1987·Diabetes/metabolism Reviews·A D CherringtonP E Williams
May 1, 1987·The Journal of Clinical Investigation·L RossettiR A DeFronzo
Apr 26, 1996·The Journal of Biological Chemistry·D MassillonL Rossetti
Jul 15, 1996·The Journal of Clinical Investigation·B R LandauS C Kalhan
Apr 29, 1998·The Journal of Clinical Investigation·K F PetersenG I Shulman
Aug 26, 1998·The Journal of Clinical Investigation·M MevorachL Rossetti
Oct 12, 1999·Journal of Applied Physiology·S CardinA D Cherrington
Jun 18, 2002·American Journal of Physiology. Endocrinology and Metabolism·Guenther BodenMaria Mozzoli
Oct 1, 1956·The American Journal of Physiology·R STEELEN ALTSZULER
Dec 3, 2003·American Journal of Physiology. Endocrinology and Metabolism·Dale S EdgertonAlan D Cherrington
Feb 26, 2004·American Journal of Physiology. Endocrinology and Metabolism·Rita BasuRobert A Rizza
Jul 23, 2005·International Journal of Clinical Practice. Supplement·R A DeFronzo
Dec 13, 2005·American Journal of Physiology. Endocrinology and Metabolism·Maria G Buse
Mar 8, 2008·Science·Renaud DentinMarc Montminy
May 7, 2009·American Journal of Physiology. Endocrinology and Metabolism·Sylvia KehlenbrinkPreeti Kishore
Dec 3, 2009·American Journal of Physiology. Endocrinology and Metabolism·Andrew T SageGeoff H Werstuck
Aug 25, 2011·American Journal of Physiology. Endocrinology and Metabolism·Rachel A JamisonRichard G Kibbey
Jan 25, 2013·The Journal of Clinical Endocrinology and Metabolism·Rita BasuRobert A Rizza
Feb 25, 2015·The Journal of Clinical Endocrinology and Metabolism·Aurora MerovciRalph A DeFronzo

❮ Previous
Next ❯

Citations

Oct 31, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Clarice Cavalero NebuloniTiago da Silva Alexandre
Feb 2, 2021·The Journal of Clinical Endocrinology and Metabolism·Xi ChenDevjit Tripathy
Jul 31, 2021·American Journal of Preventive Cardiology·Harold E BaysPeter P Toth
Oct 26, 2021·European Journal of Clinical Investigation·Sara GuerraAmalia Gastaldelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.